← Eichor
Condition: H Pylori Eradication Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: H Pylori Eradication

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradicatio
Phase 4 · 1 location(s) · Yongquan Shi · NCT07068607
Efficacy of Different Durations of Dual and Quadruple Regimens for Helicobacter Pylori Eradication
Phase 4 · 1 location(s) · Shandong University · NCT06723197
Impact of Eradication Therapy on Helicobacter Pylori Infection With Chronic Obstructive Pulmonary Disease:
Phase 1 · 1 location(s) · Zagazig University · NCT07574879
Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer
Phase 2 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06510010
Eradication of Helicobacter Pylori Improves Metabolic Syndrome Through Modulation of Gut Microbiota.
Phase 4 · 1 location(s) · Nanjing First Hospital, Nanjing Medical University · NCT07306988
Efficacy and Safety of 14-Day Vonoprazan-Based Dual Therapy Versus Quadruple Therapy for Helicobacter Pylori Eradication
NA · 2 location(s) · Yanqing Li · NCT07179159
Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspep
Phase N/A · 26 location(s) · Shanghai Jiao Tong University School of Medicine · NCT06422052
Helicobacter Pylori Infection Status and Pathological Features for Predicting Gastric Cancer Biological Behavior and Pro
Phase N/A · 3 location(s) · Chinese PLA General Hospital · NCT07724496
Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Py
Phase 2 · 1 location(s) · Tanta University · NCT07293910
7-Day Vonoprazan, High-Dose Amoxicillin, and Bismuth Therapy
Phase 4 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07232095
Prevalence and Trends of Antimicrobial Resistance of Helicobacter Pylori in Korea
Phase N/A · 1 location(s) · Seoul National University Bundang Hospital · NCT05247112
P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication
Phase N/A · 1 location(s) · Yueyue Li · NCT07285096
Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibit
NA · 1 location(s) · Kaohsiung Medical University · NCT06349486
VA Dual Sequential Therapy
Phase 4 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06929962
The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection
NA · 1 location(s) · Seoul National University Bundang Hospital · NCT02373280
The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
Phase 4 · 42 location(s) · Qilu Hospital of Shandong University · NCT04728516
Study on the Effect of Fecal Microbiota Transplantation on Eradication of Refractory Helicobacter Pylori Infection
Phase 4 · 1 location(s) · Sichuan Provincial People's Hospital · NCT07704255
Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
Phase 4 · 1 location(s) · International Agency for Research on Cancer · NCT02047994
Tegoprazan-containing Sequential for H. Pylori
NA · 1 location(s) · Seoul National University Bundang Hospital · NCT06382493
Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID fo
Phase 2/Phase 3 · 1 location(s) · First People's Hospital of Hangzhou · NCT07242456
Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection
Phase 4 · 1 location(s) · National Taiwan University Hospital · NCT04332848
Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication
Phase 4 · 2 location(s) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Banglade · NCT07537634
H. Pylori Eradication With Argon Plasma During Endoscopy
NA · 1 location(s) · Christopher C. Thompson, MD, MSc · NCT06529159
A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile
NA · 3 location(s) · Miguel O'Ryan Gallardo · NCT05926804
Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy
NA · 1 location(s) · Kaohsiung Medical University · NCT07358130
H. Pylori Screen-and-treat Study in a Population of Young Adults
Phase N/A · 7 location(s) · University of Latvia · NCT06275204
Effect of Bismuth Add-on to Dual Therapy for Helicobacter Pylori Eradication
Phase 3 · 1 location(s) · National Taiwan University Hospital · NCT07576959
CURE-H. Pylori: A Trial on the Combination of Anti-Ulcerants and Levofloxacin-Based Therapy for Helicobacter Pylori Erad
Phase 4 · 1 location(s) · Dow University of Health Sciences · NCT07344506
Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quad
Phase 4 · 1 location(s) · Xijing Hospital of Digestive Diseases · NCT06168214
Vonoprazan Evaluation Compared to Standard Triple Therapy in Helicobacter Pylori eRadication
Phase 4 · 1 location(s) · Asian Institute of Gastroenterology, India · NCT06959368
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.